Cipher Pharmaceuticals (CPH) Competitors

Cronos Group (TSE:CRON) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

Does the media refer more to CRON or CPH?

In the previous week, Cronos Group's average media sentiment score of 0.67 beat Cipher Pharmaceuticals' score of 0.00 indicating that Cronos Group is being referred to more favorably in the media.

Company	Overall Sentiment
Cronos Group	Positive
Cipher Pharmaceuticals	Neutral

Do analysts prefer CRON or CPH?

Cipher Pharmaceuticals has a consensus price target of C$14.75, suggesting a potential downside of 6.70%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Is CRON or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Cronos Group's net margin of -42.65%. Cipher Pharmaceuticals' return on equity of 17.93% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-42.65%	-4.40%	-3.73%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Do institutionals and insiders have more ownership in CRON or CPH?

4.6% of Cronos Group shares are owned by institutional investors. Comparatively, 3.2% of Cipher Pharmaceuticals shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more risk & volatility, CRON or CPH?

Cronos Group has a beta of 1.208662, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 0.558863, indicating that its share price is 44% less volatile than the S&P 500.

Which has higher valuation & earnings, CRON or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Cronos Group. Cipher Pharmaceuticals is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$130.28M	10.43	-C$32.78M	C$0.05	71.00
Cipher Pharmaceuticals	C$47.59M	8.44	C$11.41M	C$0.46	34.37

Summary

Cipher Pharmaceuticals beats Cronos Group on 8 of the 15 factors compared between the two stocks.